SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nussinovitch U, Schoenfeld Y.Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality.Autoimmun Rev2011;10:25966.
  • 2
    Szucs G, Timar O, Szekanecz Z, Der H, Kerekes G, Szamosi S, et al.Endothelial dysfunction precedes atherosclerosis in systemic sclerosis: relevance for prevention of vascular complications.Rheumatology (Oxford)2007;46:75962.
  • 3
    Veale DJ, Collidge TA, Belch JJ.Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.Ann Rheum Dis1995;54:8535.
  • 4
    Montisci R, Vacca A, Garau P, Colonna P, Ruscazio M, Passiu G, et al.Detection of early impairment of coronary flow reserve in patients with systemic sclerosis.Ann Rheum Dis2003;69:8903.
  • 5
    Vacca A, Siotto P, Cauli A, Montisci R, Garau P, Ibba V, et al.Absence of epicardial coronary stenosis in systemic sclerosis patients with severe impairment of coronary flow reserve [letter].Ann Rheum Dis2005;65:2745.
  • 6
    Hettema ME, Zhang D, de Leeuw K, Stienstra Y, Smit AJ, Kallenberg CG, et al.Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors.Arthritis Res Ther2008;10:R49.
  • 7
    Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, et al.Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.Rheumatology (Oxford)2009;48:8349.
  • 8
    Boger RH, Maas R, Schulze F, Schwedhelm E.Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: an update on patient populations with a wide range of cardiovascular risk.Pharmacol Res2009;60:4817.
  • 9
    De Gennaro Colonna V, Bianchi M, Pascale V, Ferrario P, Morelli F, Pascale W, et al.Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.Med Sci Monit2009;15:RA91101.
  • 10
    Sitia S, Gianturco L, Tomasoni L, Turiel M.Role of cardiovascular imaging in systemic autoimmune diseases.World J Cardiol2010;2:23742.
  • 11
    Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, et al.Angiographically proven coronary artery disease in scleroderma.Rheumatology (Oxford)2006;45:13958.